Navigation Links
Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat
Date:3/22/2011

DETROIT, March 22, 2011 /PRNewswire-USNewswire/ -- The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) is the first healthcare provider in Michigan to offer a new breakthrough technology designed to correct atrial fibrillation (irregular heartbeat) in patients who struggle with this potentially life-threatening heart disorder.

The new FDA-approved, state-of-the-art technology – known formally as the "Arctic Front® Cardiac CryoAblation Catheter system" – uses a specially designed coolant to chill small areas of heart tissue, in order to better control the electrical signals which determine heartbeat rate.

Atrial Fibrillation (AF), the most common heart-rhythm disorder in the U.S., occurs when the heart's upper two chambers lose their natural rhythm and begin to beat erratically.  This condition, which currently affects 3 million Americans and 7 million people worldwide, can lead to disabling or even fatal strokes, heart failure or heart disease, if left untreated.

The new "CryoAblation" (inactivation through freezing) technique is specifically designed to treat the most common form of AF, called "symptomatic paroxysmal atrial fibrillation" or "PAF." In patients with that form of AF, irregular heartbeats in the heart's upper chambers start and stop suddenly on their own for minutes or even days at a time.

The innovative and minimally invasive new procedure employs a "cryoballoon" (delivered to the heart through an arterial catheter) to bathe electricity-conducting tissue around the heart's pulmonary vein with coolant.  The chilling down of these sensitive tissues prevents them from conducting the erratic electrical signals and thus helps to restore a regular heartbeat.

In the past, many AF patients were treated with therapeutic drugs or with invasive, often traumatic open-heart surgery to repair the electrical defect.  But those approaches have often proved unsatisfactory.  Fully 5
'/>"/>

SOURCE Detroit Medical Center
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Detroit Medical Center Chooses CareTech Solutions Document Imaging System
2. International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit
3. Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative
4. Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy
5. Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season
6. EMDT, MD+DI, and Qmed Announce Virtual Event Dedicated to Developments in Materials for Medical Applications
7. Ann E. Berman To Join the Board of Directors of Cantel Medical Corp.
8. Echo Therapeutics Hires Two Seasoned Medical Device and Diagnostics Executives
9. Southern Home Medical Equipment Appoints Jerry Overcash to the Board of Directors
10. Reportlinker Adds US Medical Adhesives And Sealants Industry
11. CCS Medical Announces New President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  A new analysis of Centers ... 2015 enrollment data shows that 81 percent of seniors ... and extra discounts at certain pharmacies. The findings were ... pharmacy plans are now the foundation of Medicare Part ...
(Date:1/23/2015)... 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating ... Inc. ("Advaxis" or the "Company") (NASDAQ: ADXS ... duties to shareholders. On January 21, 2015, ... that Advaxis had misrepresented the clinical data for its ...
(Date:1/23/2015)... EAST SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology ... sites where its Phase I trial of Lixte,s lead compound, ... 5 institutions. John S. Kovach , M.D., ... trial was planned to be completed at a single site. ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... 21, 2007-Novo Nordisk today announced clinical,results from the ... -,the once-daily human GLP-1 analogue. The 26-week study ... in Diabetes) programme,and included 581 patients with type ... widely used oral antidiabetic drugs:,metformin and a sulfonylurea ...
... N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Nymox,Pharmaceutical Corporation ... the Company's recently completed studies of,NX-1207 for ... at,a series of upcoming U.S. urology meetings, ... Urological Association Meeting in,Colorado Springs. These independent ...
Cached Medicine Technology:Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 2Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 3Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 4Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2
(Date:1/22/2015)... 22, 2015 The Incredible Bulk is a ... to increase lean muscle by up to 30lbs in less ... attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , ... a step-by-step, scientific diet formula that allows the body to ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
(Date:1/22/2015)... released a new blog post explaining the main features of ... Auto insurance quotes help many drivers find the best coverage ... an agent or visit an agency for price information. These ... http://autocarinsurancebest.com/ . , Every business who relies heavily on transportation ...
(Date:1/22/2015)... 2015 A study recently published ... journal Medicine & Science in Sports & Exercise ... help reduce gastrointestinal (GI) problems associated with physical ... in the double-blind, placebo-controlled study took 10 grams ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Four years since the ... – which coincided with the marriage of Avasa & Matthew Love ... ROAD, which is scheduled for release through White Swan Records on ... that there is a sacred path available to all of us ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... Hospital staff nurses who work extended hours, work at night, ... are more likely to experience a drowsy driving episode, according ... the journal SLEEP. , The study, authored by Linda D. ... Mich., focused on data that were collected from 895 full-time ...
... symptoms, experts warn , SATURDAY, Dec. 1 (HealthDay News) -- ... season of sneezing, congestion and other woes for people with ... American Academy of Allergy, Asthma & Immunology (AAAAI). , But ... say. , "Whether it,s feasting on holiday meals, setting up ...
... The Pediatric Daytime Sleepiness Scale (PDSS) is an ... a sleep-related breathing disorder and daytime sleepiness on a ... the December 1 issue of the journal SLEEP. , ... Universitario Austral in Buenos Aires, Argentina, focused on 2,884 ...
... infections more often than men after heart surgery because ... the risks of bad outcomes, according to a study ... Co-authored by researchers from the University of Rochester Medical ... raises another red flag about transfusions, an ancient medical ...
... (Nasdaq: THOR ), a world leader in ... FDA Circulatory System Devices,Advisory Panel has recommended unanimously ... (PreMarket Approval) allowing the use of its,HeartMate II ... The HeartMate II is a continuous flow ...
... for Research, SAN JOSE, Calif., Nov. 30 Famed ... his recovery from,life threatening injuries due to those stunts. It ... has no treatment and no cure. Knievel,was unfortunately one of ... idiopathic pulmonary fibrosis (IPF) this year, the same number as,will ...
Cached Medicine News:Health News:Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy 2Health News:Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy 3Health News:Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy 4Health News:'Tis the Season For Allergy, Asthma 2Health News:PDSS reliable in measuring impact of sleep disorders on teens' academic performance 2Health News:Study links blood transfusions to surgery complications in women 2Health News:Study links blood transfusions to surgery complications in women 3Health News:Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation 2Health News:Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation 3Health News:Evel Knievel Lost to Pulmonary Fibrosis; Disease Claims as Many Lives as Breast Cancer Each Year 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: